Popular Articles

Lou Gehrig's Disease Drug Tested In Melanoma
Following evidence of tumor shrinkage in a recent clinical trial at The Cancer Institute of New Jersey (CINJ), new research has just begun to further measure the effects of a drug commonly used for Lou Gehrig"s disease (ALS) in the treatment of melanoma. CINJ is a center of excellence of UMDNJ-Robert Wood Johnson Medical School.
drugs without prescription
Protein Linked To Alzheimer's Disease Doesn't Act Alone
A team of U.S. investigators led by neuroscientists at Georgetown University Medical Center (GUMC) are steadily uncovering the role that amyloid precursor protein (APP) - the protein implicated in development of Alzheimer"s disease - plays in normal brain function. In the June 10 issue of the Journal of Neuroscience, they discovered that APP interacts with another protein known as Reelin to promote development of abundant connections between brain neurons.
News of the day
Diazyme Homocysteine Test Receives AACC Award
Dr. Chong Yuan, Managing Director of Diazyme Laboratories Division, General Atomics, received the 2009 Pacific Biometrics Research Foundation Award at the annual meeting of American Association for Clinical Chemistry (AACC) held in Chicago on July 20th, 2009.